Autoimmune hemolytic anemia in chronic mucocutaneous candidiasis
article
OA: green
CC0
Abstract
Chronic mucocutaneous candidiasis is an immunodeficiency disease characterized by T-cell dysregulation and chronic superficial candidal infections. We report on three patients with chronic mucocutaneous candidiasis who developed autoantibodies to erythrocytes. Our first patient, a 19-year-old female, developed autoimmune hemolytic anemia (AIHA) that required multiple courses of treatment, including corticosteroids, intravenous immunoglobulin, and danazol. During the last exacerbation of AIHA, intensive treatment with corticosteroids and intravenous immunoglobulin failed and yet the patient responded to plasmapheresis. Our second patient, a 21-year-old male, developed AIHA which responded to oral corticosteroid therapy. Our third patient, a 6-year-old female without evidence of hemolysis, was found to have erythrocyte autoantibodies on routine screening. These three patients had positive direct antiglobulin tests, and the first patient had both immunoglobulin G (IgG) and IgM erythrocyte autoantibodies, while the remaining two patients had only IgG autoantibody. This is the first report of the association of AIHA with chronic mucocutaneous candidiasis. We suggest that all patients with chronic mucocutaneous candidiasis be screened periodically for erythrocyte autoantibodies. Plasmapheresis, a safe ancillary procedure in the management of AIHA, may be life-saving in some cases. The occurrence of erythrocyte autoantibodies in mucocutaneous candidiasis may be related to immunoregulatory disorders in this disease.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
References (34)
- Danazol Therapy for Autoimmune Hemolytic Anemia via openalex
- Danazol therapy in autoimmune hemolytic anemia associated with systemic lupus erythematosus. via openalex
- Danazol therapy renders red cells resistant to osmotic lysis <sup>1</sup> via openalex
- doi:10.7326/0003-4819-74-6-955 via openalex
- doi:10.1542/peds.42.2.231 via openalex
- doi:10.1016/0008-8749(74)90207-x via openalex
- doi:10.1016/0090-1229(87)90016-x via openalex
- doi:10.1172/jci108196 via openalex
- doi:10.1056/nejm198702263160903 via openalex
- doi:10.1172/jci107325 via openalex
- doi:10.1172/jci104129 via openalex
- doi:10.1210/jcem-16-10-1374 via openalex
- doi:10.1001/archinte.1981.00340080112024 via openalex
- doi:10.1097/00006454-198707000-00018 via openalex
- doi:10.1056/nejm197901253000403 via openalex
- doi:10.1016/s0190-9622(08)81260-1 via openalex
- doi:10.5694/j.1326-5377.1973.tb128656.x via openalex
- doi:10.1016/s0140-6736(69)92223-5 via openalex
- doi:10.1111/j.1445-5994.1988.tb00138.x via openalex
- doi:10.1016/0002-9343(88)90106-4 via openalex
- doi:10.1016/s0140-6736(69)90264-5 via openalex
- doi:10.1007/bf00917018 via openalex
- W2399934001 via openalex
- W2409980592 via openalex
- W2413812108 via openalex
- doi:10.7326/0003-4819-88-2-226 via openalex
- doi:10.1016/s0022-3476(05)82824-0 via openalex
- doi:10.2340/0001555567257260 via openalex
- doi:10.1093/jnci/85.8.673 via openalex
- doi:10.1172/jci108283 via openalex
- doi:10.1016/s0065-2776(08)60342-9 via openalex
- doi:10.1097/00007890-198605000-00006 via openalex
- doi:10.1111/j.1365-3083.1985.tb01842.x via openalex
- doi:10.7326/0003-4819-82-6-766 via openalex
Source provenance
- openalex
- last seen: 2026-05-11T04:35:28.172353+00:00
License: CC0
· commercial use OK